Prospective dosimetry treatment planning
tumor, non-segmental (lobar or 2 adjacent segments) Y90
TUMOR
Therapeutic Y90 activity was calculated based on Tc99 MAA TNR and LSF from SPECT/CT as the current standard of care. Utilizing the partition model, patients undergoing non-segmental (lobar or 2 adjacent segments) Y90 therapies had their treatment planning with the goal to deliver > 200 Gy to the tumor and < 70 Gy to the non-tumoral liver [